Alvotech is trading 5% up at ISK 730.00 for September 29, 2026; no fresh company announcement explaining the move was found.
- Earlier positive attention followed the FDA’s closure of its Reykjavik facility inspection and Barclays’ upgrade, but reporting does not establish either as the direct cause.
- Broader market signals are mixed and do not clearly explain the rise.
- No volume or trading-activity data is available to assess activity levels.